Puma Biotechnology (PBYI) Capital Expenditures Growth (5y) (2016 - 2025)
Puma Biotechnology (PBYI) Capital Expenditures Growth (5y) (2016 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Puma Biotechnology |
384.39 Mn |
282.84 Mn |
34.39 Mn |
| Date | Value |
|---|
| Dec 31, 2025 |
-45.11% |
| Sep 30, 2025 |
18.77% |
| Jun 30, 2025 |
85.56% |
| Mar 31, 2025 |
36.23% |
| Dec 31, 2023 |
28.91% |
| Sep 30, 2023 |
-23.48% |
| Dec 31, 2022 |
-93.36% |
| Sep 30, 2022 |
121.26% |
| Dec 31, 2020 |
15.21% |
| Sep 30, 2020 |
-57.18% |
| Mar 31, 2020 |
-40.81% |
| Dec 31, 2018 |
-21.17% |
| Sep 30, 2018 |
23.47% |
| Jun 30, 2018 |
-1.32% |
| Mar 31, 2018 |
-14.22% |
| Dec 31, 2017 |
-29.78% |
| Sep 30, 2017 |
-8.07% |
| Mar 31, 2017 |
-12.08% |
| Sep 30, 2016 |
193.55% |
| Jun 30, 2016 |
287.89% |
